Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00958984 · ClinicalTrials.gov registry record
Continuous Hemoglobin Monitoring in Pediatric Transplant
A clinical trial of Pediatric Solid Organ Transplant, sponsored by University of Nebraska.
- Completed
- Registry status
- 21
- Enrollment target
- 1
- Study location
NCT00958984: Completed study of Pediatric Solid Organ Transplant, sponsored by University of Nebraska.
NCT00958984 is a study of Pediatric Solid Organ Transplant that has completed, run by University of Nebraska. The registered enrollment target is 21 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00958984, a study of Pediatric Solid Organ Transplant, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the clinical utility of non-invasive monitoring of Hemoglobin (Hgb) and Plethysmograph Variability Index (PVI) values during the intraoperative period of visceral solid organ transplantation in children. Hemoglobin values reflect oxygen-carrying capacity of the blood and PVI reflects fluid balance and perfusion.
Conditions Studied
Study Locations (1)
Nebraska
- Unversity of Nebraska Medical Center - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2009-08-11 |
| Est. Completion | 2011-11-01 |
What the finished NCT00958984 record still lists
NCT00958984 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.
The record links to 1 condition, with Pediatric Solid Organ Transplant appearing as the primary indexed condition, and to 0 interventions.
NCT00958984 reports a single indexed study location in Nebraska.
Frequently Asked Questions
What is clinical trial NCT00958984 about?
NCT00958984 is a clinical study titled "Continuous Hemoglobin Monitoring in Pediatric Transplant". The purpose of this study is to determine the clinical utility of non-invasive monitoring of Hemoglobin (Hgb) and Plethysmograph Variability Index (PVI) values during the intraoperative period of visceral solid organ transplantation in children. Hemoglobin values reflect oxygen-carrying capacity of ...
What is the current status of trial NCT00958984?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2009-08-11. Estimated completion is 2011-11-01.
What conditions does trial NCT00958984 study?
This clinical trial studies the following conditions: Pediatric Solid Organ Transplant.
Who is sponsoring clinical trial NCT00958984?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00958984 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI